ConductScience.org, home

Trial · NCT02369978

CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)

NCT02369978, Phase 2, Phase 3, Unknown, Universidad Autónoma de Bucaramanga

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY). Trials, record NCT02369978. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02369978

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
NCT number
NCT02369978
Status
Unknown
Phases
Phase 2, Phase 3
Enrollment
500 participants, estimated
Lead sponsor
Universidad Autónoma de Bucaramanga
Conditions
Chagas Disease
Interventions
Nifurtimox, Benznidazole, Placebo
First posted
2015-02-24
Last updated
2017-07-21

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryQuantitative Polymerase Chain Reaction (qPCR) for Trypanosoma cruzi12 - 18 months after starting therapyProportion of participants with at least one out of three positive tests (performed at least one week apart from each other)
SecondaryT. cruzi positive serology status12 months after starting therapyProportion of participants with positive T. cruyzi serology status
SecondaryMean change in T. cruzi antibody titers12 months after starting therapyMean change (before-after) in antibody readings as measured with ELISA serology
OtherReported adverse reactions60 days after starting therapy
Proportion of participants with at least one of the following a) Reporting hospitalization or inability to work b) Stopping study treatment because of adverse reactions /intolerance c) having abnormal levels of at least two biochemical or blood markers

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
24867876BACKGROUNDPubMed
31307503DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02369978

GET https://conductscience.org/api/trials/v1/NCT02369978/registered